Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway

Qianqian Yin1, Longyun Wang1, Haiyang Yu2

  • 1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

Frontiers in Pharmacology
|September 20, 2021
PubMed

Insights

Polyphenols like curcumin and quercetin can modulate the Janus kinase-STAT (JAK-STAT) signaling pathway, offering potential for treating inflammatory and other diseases. This review explores over 20 phytochemicals targeting this crucial pathway.

Area of Science:

  • Molecular Biology
  • Immunology
  • Pharmacology

Background:

  • The Janus kinase-STAT (JAK-STAT) signaling pathway is integral to cytokine signaling, regulating cell proliferation, apoptosis, differentiation, and inflammatory responses.
  • It plays a critical role in innate and adaptive immunity, controlling inflammatory processes.
  • Limitations exist in monotherapy targeting of the JAK-STAT pathway due to its complex interactions, with most STAT-targeting drugs in preclinical stages.

Purpose of the Study:

  • To review the pharmacological effects of various polyphenolic phytochemicals on the JAK-STAT signaling pathway.
  • To explore the potential of natural compounds in modulating aberrant JAK-STAT activation for therapeutic benefit.

Main Methods:

  • Literature review focusing on phytochemicals and their interactions with the JAK-STAT pathway.
  • Analysis of over 20 kinds of polyphenolic phytochemicals based on their chemical structures.
  • Summary of reported pharmacological effects, including anti-inflammatory, antitumor, and cardiovascular benefits.

Main Results:

  • Curcumin, quercetin, and other plant polyphenols demonstrate multi-site inhibition of abnormal JAK-STAT pathway activation.
  • Polyphenols exhibit significant therapeutic potential in managing inflammatory conditions, cancer, and cardiovascular diseases via JAK-STAT modulation.
  • The review categorizes and discusses the effects of numerous phytochemicals based on their chemical structures.

Conclusions:

  • Polyphenolic phytochemicals represent a promising class of compounds for targeting the JAK-STAT pathway.
  • Natural compounds offer a viable strategy to overcome the limitations of current JAK-STAT targeted therapies.
  • Further research into these phytochemicals could lead to novel therapeutic agents for a range of diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
13.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K